Quanome Technologies, Inc. (QNME) is a micro-cap company on the Nasdaq Capital Market, formerly known as Lakeside Holding Limited. It provides cross-border supply-chain and pharmaceutical distribution services and has recently expanded into AI computing infrastructure. Crucially, the stock has no traditional analyst coverage: financial data providers list zero covering analysts and no consensus rating or average analyst price target.
Because no credible aggregate of human analyst targets exists, this article does not use a fabricated consensus. Instead, the $0.50 figure reflects a publicly discussed technical and psychological milestone—a round-number level the stock traded above consistently through September and early October 2026 and that sits near its 50-day moving average (roughly $0.48). It is a realistic recovery objective, not a published analyst forecast. For context, TipRanks' AI analyst Spark is the only attributed target found, at $0.27 with a Neutral rating, citing weak financials and a bearish technical setup. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The stock was recently trading near $0.39, well off its 52-week high of about $1.68 and near the lower end of its $0.25–$1.68 range. Reaching $0.50 would require an increase of roughly 28%—a substantial move. The path would depend on the company's emerging AI-infrastructure narrative translating into actual revenue and on renewed speculative interest after a sharp pullback from September's spike.
In September 2026 the shares surged on announcements of a $18.8 million purchase of 32 GPU servers from Compal Electronics and a first enterprise customer agreement for its XDT AI-inference business, described as a 60-month order exceeding $100 million in total commitment value, with a $13.5 million prepayment received. However, the stock gave back most of those gains, reflecting skepticism about execution.
The stock's 52-week range of roughly $0.25 to $1.68 defines a wide, volatile trading band. The $0.50 level is a psychological round number and sits near the 50-day moving average (about $0.48), making it a natural resistance area. Above that, the 200-day moving average near $0.63 represents a further hurdle. On the downside, the 52-week low near $0.25 marks a key support level. These wide, loosely defined zones reflect a low-priced, momentum-driven security rather than a tightly valued one.
Analyst price targets typically reflect a roughly 12-month research horizon, but no such targets exist here. Without a formal horizon, investors should focus on catalysts: the next earnings report (estimated for mid-November 2026), whether the XDT AI-inference agreements convert into recognized revenue, the status of the Nasdaq listing-deficiency notice, any further share issuance, and overall AI-sector sentiment. Rate decisions and broader risk appetite also matter for speculative micro-caps.
In my own work, I rely on Tickeron's AI Daily Buy/Sell Signals to monitor names with limited coverage like this one. The platform applies AI to thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical shifts and market conditions. For thinly traded micro-caps, it helps surface potential turning points faster than manual review alone, though it remains one input among many when evaluating opportunities.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day RSI Indicator for QNME moved out of overbought territory on October 09, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 6 instances where the indicator moved out of the overbought zone. In 6 of the 6 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QNME as a result. In 43 of 47 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for QNME turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In 23 of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
QNME moved below its 50-day moving average on October 20, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for QNME crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QNME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for QNME entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +3.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where QNME advanced for three days, in 92 of 104 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.943) is normal, around the industry mean (2.483). P/E Ratio (-1.621) is within average values for comparable stocks, (7.339). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.110). Dividend Yield (0.000) settles around the average of (0.020) among similar stocks. P/S Ratio (0.242) is also within normal values, averaging (2.034).
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. QNME’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QNME’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry OtherTransportation